Michaela Reagan
Michaela Reagan
Maine Health Institute for Research
Verified email at - Homepage
Cited by
Cited by
BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
AM Roccaro, A Sacco, P Maiso, AK Azab, YT Tai, M Reagan, F Azab, ...
The Journal of clinical investigation 123 (4), 1542-1555, 2013
Electrospun silk biomaterial scaffolds for regenerative medicine
X Zhang, MR Reagan, DL Kaplan
Advanced drug delivery reviews 61 (12), 988-1006, 2009
CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications
YT Tai, Y Landesman, C Acharya, Y Calle, MY Zhong, M Cea, ...
Leukemia 28 (1), 155-165, 2014
Blocking FSH induces thermogenic adipose tissue and reduces body fat
P Liu, Y Ji, T Yuen, E Rendina-Ruedy, VE DeMambro, S Dhawan, ...
Nature 546 (7656), 107-112, 2017
Engineered nanomedicine for myeloma and bone microenvironment targeting
A Swami, MR Reagan, P Basto, Y Mishima, N Kamaly, S Glavey, S Zhang, ...
Proceedings of the National Academy of Sciences 111 (28), 10287-10292, 2014
Concise review: mesenchymal stem cell tumor-homing: detection methods in disease model systems
MR Reagan, DL Kaplan
Stem cells 29 (6), 920-927, 2011
Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma
D Harmer, C Falank, MR Reagan
Frontiers in endocrinology 9, 788, 2019
Multiple myeloma in the marrow: pathogenesis and treatments
H Fairfield, C Falank, L Avery, MR Reagan
Annals of the New York Academy of Sciences 1364 (1), 32-51, 2016
Human bone marrow–derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis
RH Goldstein, MR Reagan, K Anderson, DL Kaplan, M Rosenblatt
Cancer research 70 (24), 10044-10050, 2010
LNA-mediated anti–miR-155 silencing in low-grade B-cell lymphomas
Y Zhang, AM Roccaro, C Rombaoa, L Flores, S Obad, SM Fernandes, ...
Blood, The Journal of the American Society of Hematology 120 (8), 1678-1686, 2012
Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma
MM McDonald, MR Reagan, SE Youlten, ST Mohanty, A Seckinger, ...
Blood, The Journal of the American Society of Hematology 129 (26), 3452-3464, 2017
Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects
MR Reagan, IM Ghobrial
Clinical Cancer Research 18 (2), 342-349, 2012
SDF-1 inhibition targets the bone marrow niche for cancer therapy
AM Roccaro, A Sacco, WG Purschke, M Moschetta, K Buchner, C Maasch, ...
Cell reports 9 (1), 118-128, 2014
Navigating the bone marrow niche: translational insights and cancer-driven dysfunction
MR Reagan, CJ Rosen
Nature Reviews Rheumatology 12 (3), 154-168, 2016
Spider silk-based gene carriers for tumor cell-specific delivery
K Numata, MR Reagan, RH Goldstein, M Rosenblatt, DL Kaplan
Bioconjugate chemistry 22 (8), 1605-1610, 2011
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal-transition-like transcriptional activation
AM Roccaro, Y Mishima, A Sacco, M Moschetta, YT Tai, J Shi, Y Zhang, ...
Cell reports 12 (4), 622-635, 2015
The skeletal cell‐derived molecule sclerostin drives bone marrow adipogenesis
H Fairfield, C Falank, E Harris, V Demambro, M McDonald, JA Pettitt, ...
Journal of cellular physiology 233 (2), 1156-1167, 2018
Silk fibroin and silk-based biomaterial derivatives for ideal wound dressings
PP Patil, MR Reagan, RA Bohara
International journal of biological macromolecules 164, 4613-4627, 2020
The cancer glycome: carbohydrates as mediators of metastasis
SV Glavey, D Huynh, MR Reagan, S Manier, M Moschetta, Y Kawano, ...
Blood reviews 29 (4), 269-279, 2015
Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model
MR Reagan, Y Mishima, SV Glavey, Y Zhang, S Manier, ZN Lu, ...
Blood, The Journal of the American Society of Hematology 124 (22), 3250-3259, 2014
The system can't perform the operation now. Try again later.
Articles 1–20